Global Human Coagulation Factor VII Market Size, Share, Trends and Forecast 2022-2030

Description

Market Analysis and Insights: Global Human Coagulation Factor VII Market
Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activated factor VII is also available, but does not play any considerable role in the market.

Due to the COVID-19 pandemic, the global Human Coagulation Factor VII market size is estimated to be worth US$ 2520.1 million in 2022 and is forecast to a readjusted size of US$ 4368 million by 2028 with a CAGR of 9.6% during the review period. Fully considering the economic change by this health crisis, Recombinant Factor VIII accounting for % of the Human Coagulation Factor VII global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hemophilia A segment is altered to an % CAGR throughout this forecast period.

Europe and North America are the largest region of Human Coagulation Factor VII, with about 40% market share respectively. NovoNordisk is the major manufacturer of industry.

Market Segments

The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.

Segment by Type

Recombinant Factor VIII

Plasma-derived Factor VIII

Segment by Application

Hemophilia A

Spontanous / Trauma

Surgical

Others

Consequence of Covid-19 Pandemic

The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Human Coagulation Factor VII market back to the pre-covid levels.

Trends & Prospects

In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

U.A.E

Competitive Outlook

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

NovoNordisk

TABLE OF CONTENT

1 Study Coverage
1.1 Human Coagulation Factor VII Product Introduction

1.2 Market by Type

1.2.1 Global Human Coagulation Factor VII Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Recombinant Factor VIII

1.2.3 Plasma-derived Factor VIII

1.3 Market by Application

1.3.1 Global Human Coagulation Factor VII Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Hemophilia A

1.3.3 Spontanous / Trauma

1.3.4 Surgical

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Executive Summary

2.1 Global Human Coagulation Factor VII Sales Estimates and Forecasts 2017-2028

2.2 Global Human Coagulation Factor VII Revenue Estimates and Forecasts 2017-2028

2.3 Global Human Coagulation Factor VII Revenue by Region: 2017 VS 2021 VS 2028

2.4 Global Human Coagulation Factor VII Sales by Region

2.4.1 Global Human Coagulation Factor VII Sales by Region (2017-2022)

2.4.2 Global Sales Human Coagulation Factor VII by Region (2023-2028)

2.5 Global Human Coagulation Factor VII Revenue by Region

2.5.1 Global Human Coagulation Factor VII Revenue by Region (2017-2022)

2.5.2 Global Human Coagulation Factor VII Revenue by Region (2023-2028)

2.6 North America

2.7 Europe

2.8 Asia-Pacific

2.9 Latin America

2.10 Middle East & Africa

3 Competition by Manufacturers

3.1 Global Human Coagulation Factor VII Sales by Manufacturers

3.1.1 Global Top Human Coagulation Factor VII Manufacturers by Sales (2017-2022)

3.1.2 Global Human Coagulation Factor VII Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Coagulation Factor VII in 2021

3.2 Global Human Coagulation Factor VII Revenue by Manufacturers

3.2.1 Global Human Coagulation Factor VII Revenue by Manufacturers (2017-2022)

3.2.2 Global Human Coagulation Factor VII Revenue Market Share by Manufacturers (2017-2022)

3.2.3 Global Top 10 and Top 5 Companies by Human Coagulation Factor VII Revenue in 2021

3.3 Global Human Coagulation Factor VII Sales Price by Manufacturers (2017-2022)

3.4 Analysis of Competitive Landscape

3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Human Coagulation Factor VII Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4.3 Global Human Coagulation Factor VII Manufacturers Geographical Distribution

3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Human Coagulation Factor VII Sales by Type

4.1.1 Global Human Coagulation Factor VII Historical Sales by Type (2017-2022)

4.1.2 Global Human Coagulation Factor VII Forecasted Sales by Type (2023-2028)

4.1.3 Global Human Coagulation Factor VII Sales Market Share by Type (2017-2028)

4.2 Global Human Coagulation Factor VII Revenue by Type

4.2.1 Global Human Coagulation Factor VII Historical Revenue by Type (2017-2022)

4.2.2 Global Human Coagulation Factor VII Forecasted Revenue by Type (2023-2028)

4.2.3 Global Human Coagulation Factor VII Revenue Market Share by Type (2017-2028)

4.3 Global Human Coagulation Factor VII Price by Type

4.3.1 Global Human Coagulation Factor VII Price by Type (2017-2022)

4.3.2 Global Human Coagulation Factor VII Price Forecast by Type (2023-2028)

5 Market Size by Application

5.1 Global Human Coagulation Factor VII Sales by Application

5.1.1 Global Human Coagulation Factor VII Historical Sales by Application (2017-2022)

5.1.2 Global Human Coagulation Factor VII Forecasted Sales by Application (2023-2028)

5.1.3 Global Human Coagulation Factor VII Sales Market Share by Application (2017-2028)

5.2 Global Human Coagulation Factor VII Revenue by Application

5.2.1 Global Human Coagulation Factor VII Historical Revenue by Application (2017-2022)

5.2.2 Global Human Coagulation Factor VII Forecasted Revenue by Application (2023-2028)

5.2.3 Global Human Coagulation Factor VII Revenue Market Share by Application (2017-2028)

5.3 Global Human Coagulation Factor VII Price by Application

5.3.1 Global Human Coagulation Factor VII Price by Application (2017-2022)

5.3.2 Global Human Coagulation Factor VII Price Forecast by Application (2023-2028)

6 North America

6.1 North America Human Coagulation Factor VII Market Size by Type

6.1.1 North America Human Coagulation Factor VII Sales by Type (2017-2028)

6.1.2 North America Human Coagulation Factor VII Revenue by Type (2017-2028)

6.2 North America Human Coagulation Factor VII Market Size by Application

6.2.1 North America Human Coagulation Factor VII Sales by Application (2017-2028)

6.2.2 North America Human Coagulation Factor VII Revenue by Application (2017-2028)

6.3 North America Human Coagulation Factor VII Market Size by Country

6.3.1 North America Human Coagulation Factor VII Sales by Country (2017-2028)

6.3.2 North America Human Coagulation Factor VII Revenue by Country (2017-2028)

6.3.3 U.S.

6.3.4 Canada

7 Europe

7.1 Europe Human Coagulation Factor VII Market Size by Type

7.1.1 Europe Human Coagulation Factor VII Sales by Type (2017-2028)

7.1.2 Europe Human Coagulation Factor VII Revenue by Type (2017-2028)

7.2 Europe Human Coagulation Factor VII Market Size by Application

7.2.1 Europe Human Coagulation Factor VII Sales by Application (2017-2028)

7.2.2 Europe Human Coagulation Factor VII Revenue by Application (2017-2028)

7.3 Europe Human Coagulation Factor VII Market Size by Country

7.3.1 Europe Human Coagulation Factor VII Sales by Country (2017-2028)

7.3.2 Europe Human Coagulation Factor VII Revenue by Country (2017-2028)

7.3.3 Germany

7.3.4 France

7.3.5 U.K.

7.3.6 Italy

7.3.7 Russia

8 Asia Pacific

8.1 Asia Pacific Human Coagulation Factor VII Market Size by Type

8.1.1 Asia Pacific Human Coagulation Factor VII Sales by Type (2017-2028)

8.1.2 Asia Pacific Human Coagulation Factor VII Revenue by Type (2017-2028)

8.2 Asia Pacific Human Coagulation Factor VII Market Size by Application

8.2.1 Asia Pacific Human Coagulation Factor VII Sales by Application (2017-2028)

8.2.2 Asia Pacific Human Coagulation Factor VII Revenue by Application (2017-2028)

8.3 Asia Pacific Human Coagulation Factor VII Market Size by Region

8.3.1 Asia Pacific Human Coagulation Factor VII Sales by Region (2017-2028)

8.3.2 Asia Pacific Human Coagulation Factor VII Revenue by Region (2017-2028)

8.3.3 China

8.3.4 Japan

8.3.5 South Korea

8.3.6 India

8.3.7 Australia

8.3.8 Taiwan

8.3.9 Indonesia

8.3.10 Thailand

8.3.11 Malaysia

8.3.12 Philippines

9 Latin America

9.1 Latin America Human Coagulation Factor VII Market Size by Type

9.1.1 Latin America Human Coagulation Factor VII Sales by Type (2017-2028)

9.1.2 Latin America Human Coagulation Factor VII Revenue by Type (2017-2028)

9.2 Latin America Human Coagulation Factor VII Market Size by Application

9.2.1 Latin America Human Coagulation Factor VII Sales by Application (2017-2028)

9.2.2 Latin America Human Coagulation Factor VII Revenue by Application (2017-2028)

9.3 Latin America Human Coagulation Factor VII Market Size by Country

9.3.1 Latin America Human Coagulation Factor VII Sales by Country (2017-2028)

9.3.2 Latin America Human Coagulation Factor VII Revenue by Country (2017-2028)

9.3.3 Mexico

9.3.4 Brazil

9.3.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Human Coagulation Factor VII Market Size by Type

10.1.1 Middle East and Africa Human Coagulation Factor VII Sales by Type (2017-2028)

10.1.2 Middle East and Africa Human Coagulation Factor VII Revenue by Type (2017-2028)

10.2 Middle East and Africa Human Coagulation Factor VII Market Size by Application

10.2.1 Middle East and Africa Human Coagulation Factor VII Sales by Application (2017-2028)

10.2.2 Middle East and Africa Human Coagulation Factor VII Revenue by Application (2017-2028)

10.3 Middle East and Africa Human Coagulation Factor VII Market Size by Country

10.3.1 Middle East and Africa Human Coagulation Factor VII Sales by Country (2017-2028)

10.3.2 Middle East and Africa Human Coagulation Factor VII Revenue by Country (2017-2028)

10.3.3 Turkey

10.3.4 Saudi Arabia

11 Company Profiles

11.1 NovoNordisk

11.1.1 NovoNordisk Corporation Information

11.1.2 NovoNordisk Overview

11.1.3 NovoNordisk Human Coagulation Factor VII Sales, Price, Revenue and Gross Margin (2017-2022)

11.1.4 NovoNordisk Human Coagulation Factor VII Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 NovoNordisk Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Human Coagulation Factor VII Industry Chain Analysis

12.2 Human Coagulation Factor VII Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Human Coagulation Factor VII Production Mode & Process

12.4 Human Coagulation Factor VII Sales and Marketing

12.4.1 Human Coagulation Factor VII Sales Channels

12.4.2 Human Coagulation Factor VII Distributors

12.5 Human Coagulation Factor VII Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

13.1 Human Coagulation Factor VII Industry Trends

13.2 Human Coagulation Factor VII Market Drivers

13.3 Human Coagulation Factor VII Market Challenges

13.4 Human Coagulation Factor VII Market Restraints

14 Key Findings in The Global Human Coagulation Factor VII Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

Choose License Type

Checkout Inquiry Sample